Yazaki, M.; Nabeta, T.; Takigami, Y.; Eda, Y.; Fujita, T.; Iida, Y.; Ikeda, Y.; Ishii, S.; Ako, J.
Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure. Medicina 2024, 60, 84.
https://doi.org/10.3390/medicina60010084
AMA Style
Yazaki M, Nabeta T, Takigami Y, Eda Y, Fujita T, Iida Y, Ikeda Y, Ishii S, Ako J.
Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure. Medicina. 2024; 60(1):84.
https://doi.org/10.3390/medicina60010084
Chicago/Turabian Style
Yazaki, Mayu, Takeru Nabeta, Yu Takigami, Yuko Eda, Teppei Fujita, Yuichiro Iida, Yuki Ikeda, Shunsuke Ishii, and Junya Ako.
2024. "Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure" Medicina 60, no. 1: 84.
https://doi.org/10.3390/medicina60010084
APA Style
Yazaki, M., Nabeta, T., Takigami, Y., Eda, Y., Fujita, T., Iida, Y., Ikeda, Y., Ishii, S., & Ako, J.
(2024). Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure. Medicina, 60(1), 84.
https://doi.org/10.3390/medicina60010084
